Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tylenol Arthritis Pain Caplets on recall

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare expands a voluntary recall of its arthritis analgesic from five lots to all available lots following consumer reports of a moldy odor associated with the product. The Johnson & Johnson unit and FDA said Dec. 18 certain lots of the Tylenol Arthritis Pain product in 100-count bottles had traces of a chemical from treated wooden pallets, though all adverse events associated with the resulting odor have been temporary and non-serious. McNeil said it plans to move production to a new facility and reintroduce the product

Related Content

McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts